急性肺栓塞的闪烁显像诊断:从基础到最佳实践
本文综述了肺闪烁显像诊断急性肺栓塞的技术、判读和诊断效能,对比了V/Q显像与CTPA的原理差异,介绍了常用通气与灌注显像药物及平面和断层方法,并提及妊娠期和疫情期间减少辐射与传染风险的操作策略。
要点
- 肺闪烁显像经时间验证是诊断肺栓塞可靠且经验证的检查方法。
- V/Q显像评估血栓对下游血管床的功能影响及受累肺区通气状态,不同于CTPA直接显示血管内血栓。
- 妊娠期乳腺组织放射敏感,许多指南推荐使用肺闪烁显像而非CTPA。
核心结论
- 肺闪烁显像在急性肺栓塞诊断中继续发挥重要临床和研究作用。
研究设计与样本
- 本文为综述,回顾了肺闪烁显像诊断急性肺栓塞的技术、判读和诊断效能。
主要发现
- V/Q显像评估血栓对下游血管床的功能影响及受累肺区通气状态,CTPA则显示受累血管内血栓。
- 常用通气放射性药物为锝-99m标记气溶胶(如99mTc-DTPA)或超细颗粒悬浮液(99mTc-Technegas),灌注显像经静脉注射99mTc标记大颗粒聚合白蛋白后获得。
- 平面和断层显像方法在不同地理区域各有偏好。
关键数值与推荐
- 美国核医学与分子影像学会和欧洲核医学协会均发布了闪烁显像判读指南。
- 妊娠期乳腺组织因高度增殖状态对放射敏感,许多指南推荐该人群使用肺闪烁显像而非CTPA。
- 减少辐射暴露的操作包括降低放射性药物剂量或省略通气显像,将检查功能性地转为低剂量筛查;若存在灌注缺损,需进一步检查。
- 疫情期间多个团队采用仅灌注显像以降低呼吸道传染风险;若存在灌注缺损,同样需进一步检查以避免假阳性。
临床怎么用
- 妊娠期许多指南推荐使用肺闪烁显像而非CTPA。
- 为减少辐射暴露可降低放射性药物剂量或省略通气显像,若存在灌注缺损需进一步检查。
- 疫情期间多个团队采用仅灌注显像以减少呼吸道传染风险,若存在灌注缺损需进一步检查;随着个人防护装备供应改善和严重感染风险降低,该操作在多数实践中已无必要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this article the technique, interpretation, and diagnostic performance of scintigraphy for the diagnosis of acute pulmonary embolism (PE) are reviewed. Lung scintigraphy has stood the test of time as a reliable and validated examination for the determination of PE. Ventilation/perfusion (V/Q) lung scintigraphy assesses the functional consequences of the clot on its downstream vascular bed in conjunction with the underlying ventilatory status of the affected lung region, in contrast to CT pulmonary angiography (CTPA), which visualizes presence of the clot within affected vessels. Most-commonly used ventilation radiopharmaceuticals are Technetium-99m labeled aerosols (such as 99mTechnetium-DTPA), or ultrafine particle suspensions (99mTc-Technegas) which reach the distal lung in proportion to regional distribution of ventilation. Perfusion images are obtained after intravenous administration 99mTc-labeled macro-aggregated albumin particles which lodge in the distal pulmonary capillaries. Both planar and tomographic methods of imaging, each favored in different geographical regions, will be described. Guidelines for interpretation of scintigraphy have been issues by both the Society of Nuclear Medicine and Molecular Imaging, and by the European Association of Nuclear Medicine. Breast tissue is particularly radiosensitive during pregnancy due to its highly proliferative state and many guidelines recommend use of lung scintigraphy rather than CTPA in this population. Several maneuvers are available in order to further reduce radiation exposure including reducing radiopharmaceutical dosages or omitting ventilation altogether, functionally converting the study to a low-dose screening examination; if perfusion defects are present, further testing is necessary. Several groups have also performed perfusion-only studies during the COVID epidemic in order to reduce risk of respiratory contagion. In patients where perfusion defects are present, further testing is again necessary to avoid false-positive results. Improved availability of personal protective equipment, and reduced risk of serious infection, have rendered this maneuver moot in most practices. First introduced 60 years ago, subsequent advances in radiopharmaceutical development and imaging methods have positioned lung scintigraphy to continue to play an important clinical and research role in the diagnosis of acute PE.
引用
- Le Roux PY, Le Pennec R, Salaun PY, et al. Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices. Semin Nucl Med. 2023. PMID: 37142520. doi:10.1053/j.semnuclmed.2023.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。